SEC Form 4 · accession 0001144204-17-032761
Checkpoint Therapeutics, Inc. · CKPT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael S Weiss
Director
Period of report
Jun 15, 2017
Accepted (ET)
Jun 15, 2017 · 5:16 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001651407
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCKF1,F2 | Jun 15, 2017 | A | 10,000 | $0.00 | A | 10,000 | I | See Note 2 |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The 10,000 shares of restricted Common Stock will vest on June 15, 2020.
- F2The shares were issued to and are held by Caribe BioAdvisors, LLC, of which Mr. Weiss is the sole member.